Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis. - Wikidata - awgldk - TriplyDB

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

http://www.wikidata.org/entity/Q34802423

about

Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis Cost-utility analysis of nonalcoholic steatohepatitis screening.Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice--an exploratory case-control study Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Hepatic steatosis and steatohepatitis: Are they really two distinct entities?Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.ER stress-mediated cell damage contributes to the release of EDA+ fibronectin from hepatocytes in nonalcoholic fatty liver disease.The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment.Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease

P2860

Q26852019-3F29CD07-2930-4D6A-A162-E07343EE4575 Q26858875-0CD284DF-8C02-4641-9AD5-6299101BC388 Q30385602-563ACC7C-4AEA-4E44-9D7F-D94B59883343 Q30414504-92AB0AB7-F016-47F8-A3BD-988CF5D03BAB Q34414807-EB21329F-5D1C-4AD7-BE30-A9A9046A0D74 Q36795373-B8650F4E-4AF6-4352-A766-E8F2483D84D3 Q37581357-F6B85195-1A87-4973-A18F-D28A424C8D44 Q37689828-7DD12A90-F353-4388-90A4-5AA83B51D5BB Q38224490-15666EA7-C6F8-4FD4-B216-A8019B93490F Q38246145-61A86250-E629-4580-980C-E8BA5ACCA831 Q38676257-85271BFC-940F-4E1F-B70A-22F073389DC0 Q38708143-6B4D2146-3B5E-4350-8152-5E8F9BBA119B Q39410610-737159D5-EFCF-431B-9021-065FD737187A Q40513071-48D399B1-B153-4F90-BD7A-CFB8561CEC8C Q57494353-8A75BC24-0320-41E9-83CD-02D5C9506D0C Q58549444-5E484120-F3B9-4A15-875C-ACDE949005B4

P2860

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

http://www.wikidata.org/entity/Q34802423

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

@ast

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

@en

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

@nl

type

label

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

@ast

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

@en

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

@nl

prefLabel

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

@ast

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

@en

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

@nl

P1433

Q34802423-B52E4DCB-7D52-4A3E-A6B3-B8B98708415A

P1476

Q34802423-647852F6-2DC6-475D-B67B-5C0E74B0CE27

P2093

Q34802423-417F1BE1-2D7F-435B-B467-52D956A22157

Q34802423-8DBBA821-A8DD-46D2-8C24-FE92E42AABDB

Q34802423-C0D613D8-0083-4E90-8B54-96B555B54862

Q34802423-D138EE92-D1AC-4B24-84E5-908000278A0F

P2860

Q34802423-02E46DBB-B303-465E-8C9A-12B07B398505

Q34802423-081BDB13-C8DD-4893-BC8F-00178A15F999

Q34802423-0A276D9C-BB19-4A84-BBC2-F3627941DAE8

Q34802423-0C1AE3EB-07BA-49FA-8641-98958AE69297

Q34802423-0E332ABE-61BA-477B-9733-FA181F42E86A

Q34802423-10A30FA0-0466-4632-9E04-0027CC49A936

Q34802423-194F9441-ED01-48A6-AB92-8D2E3F3EB09E

Q34802423-1DE7256A-A410-4E6E-BAF4-69133E46AD11

Q34802423-21C68950-F237-4991-898F-BFC37B2A121D

Q34802423-27C219F6-041F-4EE3-971D-0244BD1E5385

P304

Q34802423-BB0C79B6-06A2-4D46-AA61-441B928416AA

P31

Q34802423-A189561B-FF57-4335-9AD0-0A284691C685

P356

Q34802423-753E0035-3455-4F37-9010-81EEB951CE7D

P433

Q34802423-1AC0DB6F-096B-4717-8283-B8CC68450662

P478

Q34802423-BAA0728D-0DEA-4A34-81D3-84DB0EC14AF9

P577

Q34802423-4BD78993-EF4C-4CBA-9A9B-C69C82ADF0EB

P698

Q34802423-65267E1D-DA53-4C59-B9B6-7B6E0ED527DA

P921

Q34802423-4DEA82F7-49FC-4473-901A-2FDD14DB03B2

Q34802423-7AA28F9D-5CB5-435A-88F1-275C2C864A97

P356

P1433

Hepatology Research

P1476

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

@en

P2093

Jiaji Jiang

http://www.w3.org/2001/XMLSchema#string

Jing Chen

http://www.w3.org/2001/XMLSchema#string

Qi Zheng

http://www.w3.org/2001/XMLSchema#string

Yueyong Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

Bias in meta-analysis detected by a simple, graphical test

Conducting systematic reviews of diagnostic studies: didactic guidelines.

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

Measuring inconsistency in meta-analyses

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

Dissemination and publication of research findings: an updated review of related biases

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease.

Meta-DiSc: a software for meta-analysis of test accuracy data.

P304

854-862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HEPR.12197

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23834322

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis